Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Izuchukwu K. Ibe"'
Autor:
Jungho Back, Minh Nam Nguyen, Lu Li, Saelim Lee, Inkyu Lee, Fancheng Chen, Lauren Gillinov, Yeon-Ho Chung, Kareme D. Alder, Hyuk-Kwon Kwon, Kristin E. Yu, Christopher M. Dussik, Zichen Hao, Michael J. Flores, Yoseph Kim, Izuchukwu K. Ibe, Alana M. Munger, Sung Wook Seo, Francis Y. Lee
Publikováno v:
Bone Research, Vol 9, Iss 1, Pp 1-14 (2021)
Abstract Disruption of bone homeostasis caused by metastatic osteolytic breast cancer cells increases inflammatory osteolysis and decreases bone formation, thereby predisposing patients to pathological fracture and cancer growth. Alteration of osteob
Externí odkaz:
https://doaj.org/article/be04f427e4a7463ca43298e5ceafb353
Autor:
Ahmed Aoude, David Nikomarov, Jonathan R. Perera, Izuchukwu K. Ibe, Anthony M. Griffin, Kim M. Tsoi, Peter C. Ferguson, Jay S. Wunder
Publikováno v:
The Bone & Joint Journal. :559-567
AimsGiant cell tumour of bone (GCTB) is a locally aggressive lesion that is difficult to treat as salvaging the joint can be associated with a high rate of local recurrence (LR). We evaluated the risk factors for tumour relapse after treatment of a G
Autor:
Zichen Hao, Inkyu Lee, Lu Li, Christopher M. Dussik, Jung Ho Back, Sung Wook Seo, Izuchukwu K Ibe, Minh Nam Nguyen, Michael J. Flores, Fancheng Chen, Hyuk-Kwon Kwon, Alana M. Munger, Kristin E. Yu, Francis Y. Lee, Saelim Lee, Lauren Gillinov, Yoseph Kim, Yeon-Ho Chung, Kareme D Alder
Publikováno v:
Bone Research, Vol 9, Iss 1, Pp 1-14 (2021)
Bone Research
Bone Research
Disruption of bone homeostasis caused by metastatic osteolytic breast cancer cells increases inflammatory osteolysis and decreases bone formation, thereby predisposing patients to pathological fracture and cancer growth. Alteration of osteoblast func
Autor:
Izuchukwu K Ibe, Dieter M. Lindskog, Andre M. Samuel, Gary E. Friedlaender, Francis Y. Lee, Alana M. Munger
Publikováno v:
Orthopedics. 43
In the humerus, pain is a poor guide for differentiating between benign enchondromas and malignant well-differentiated chondrosarcomas. Radionuclide bone scans often are used, and chondrosarcomas reliably show increased uptake. However, it remains to
Publikováno v:
JBJS case connector. 10(2)
CASE A 72-year-old morbidly obese nonambulatory woman with bilateral chronically infected revision knee prostheses and incompetent extensor mechanisms who uses a wheelchair had limited functionality and presented with recalcitrant chronic infection w
Autor:
Dieter M. Lindskog, Douglas Rottmann, Izuchukwu K Ibe, Devin Conway, Jose Costa, Alana M. Munger
Publikováno v:
JBJS case connector. 10(1)
CASE A 63 year-old woman presented with a multiple-year history of right knee pain and effusions and pain refractory to numerous knee aspirations and an arthroscopic synovectomy. The patient underwent a 2-incision synovectomy and intralesional resect
Publikováno v:
Instructional course lectures. 68
Advancements in medical and radiation oncology have improved the prognosis for many cancers during the past few decades. As a result, physicians are challenged with managing a greater burden of disease for a longer time. In orthopaedics, bone loss se
Autor:
Shasta E, Henderson, Kristin, Yu, Kareme D, Alder, Izuchukwu K, Ibe, Francis Y, Lee, Dieter M, Lindskog
Publikováno v:
Instructional course lectures. 68
Skeletal metastases of the femur and tibia leading to pathologic fractures or large skeletal defects can be managed with surgical reconstruction, resulting in improved patient outcomes and functionality. The indications for femoral and tibial reconst
Publikováno v:
Instructional course lectures. 68
Metastatic bone disease is a substantial driver of morbidity and mortality in many cancers. The presence of bone metastases often indicates a worse prognosis for patients. The mechanisms underlying bone metastases and bone loss are complex and involv
Autor:
Gary E. Friedlaender, Izuchukwu K Ibe, Andrew Koo, Dieter M. Lindskog, Francis Y. Lee, Monique S. Haynes
Publikováno v:
Tech Orthop
The future of cancer treatment is promising. Although marred by years of plateau in outcomes, new avenues have been identified that are poised to change how we treat cancer. Molecular targeted therapy or targeted therapy is one of these methods. Mole